(Q34796994)

4 August 2017

1 reference

title

Recombinant human activated protein C for use in severe sepsis (English)

1 reference

4 August 2017

0 references

1 reference

David T Bearden

1

1 reference

4 August 2017

Cory G Garvin

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Annals of Pharmacotherapy

4 August 2017

published in

1 reference

4 August 2017

volume

36

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1424-1429

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

4 August 2017

cites work

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

Clinical trials for severe sepsis. Past failures, and future hopes

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation

21 January 2018

1 reference

The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease

21 January 2018

1 reference

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

21 January 2018

1 reference

Protein S and C alterations in acutely ill patients

21 January 2018

1 reference

Low levels of protein C are associated with poor outcome in severe sepsis

21 January 2018

1 reference

The importance of antibiotic pharmacokinetics in critical illness

21 January 2018

1 reference

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

21 January 2018

1 reference

Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics

21 January 2018

1 reference

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

21 January 2018

1 reference

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A445

1 reference

4 August 2017

1 reference